临床试验/CTIS2022-501696-91-00

CTIS2022-501696-91-00进行中（未招募）1 期

NGF1

niversitair Ziekenhuis Gent0 个研究点目标入组 10 人开始时间: 2023年9月14日最近更新: 2024年7月22日

适应症

试验速览

阶段: 1 期
状态: 进行中（未招募）
发起方
入组人数: 10

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 18 至 65+（—）
性别: All

入选标准

未提供

排除标准

未提供

研究者

发起方

niversitair Ziekenhuis Gent

相似试验

进行中（未招募）

A Phase I Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 against Crimean Congo Hemorrhagic Fever (CCHF-NP-1)Crimean Congo Hemorrhagic FeverMedDRA version: 20.1Level: PTClassification code: 10010685Term: Congo-Crimean haemorrhagic fever Class: 100000004862

CTIS2023-508556-18-00Karolinska Institutet15

Study of SGN-PDL1V in Advanced Solid Tumors

CTIS2023-506604-18-00Seagen Inc.322

Effects of exercise program on fall risk reduction in pre-frail older adultspre&#45frailProgram exercise&#44Risk of fall&#44

TCTR20180806001Faculty of Medicine Chiang Mai University72

进行中（未招募）

A Phase 1 Study of SGN-ALPV in Advanced Solid Tumorsgastroesophageal junction [GEJ] carcinoma, Non-small cell lung cancer (NSCLC), Gastric cancer, Cervical cancer, Ovarian cancer, Endometrial cancer, Malignant ovarian GCT with the exception of pure teratomas, Malignant testicular germ cell tumor (GCT) with the exception of pure teratomas, Gastroesophageal junction carcinoma, Malignant extragonadal GCT with the exception of pure teratomas or tumors with primaries arising from the central nervous system (CNS)MedDRA version: 21.1Level: LLTClassification code: 10043338Term: Testicular malignant germ cell tumor NOS Class: 10029104MedDRA version: 21.1Level: PTClassification code: 10017758Term: Gastric cancer Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 20.0Level: HLTClassification code: 10033222Term: Ovarian germ cell neoplasms malignant Class: 10029104MedDRA version: 21.1Level: LLTClassification code: 10008229Term: Cervical cancer Class: 10029104MedDRA version: 21.0Level: PTClassification code: 10014733Term: Endometrial cancer Class: 100000004864MedDRA version: 21.1Level: LLTClassification code: 10066354Term: Adenocarcinoma of the gastroesophageal junction Class: 10029104MedDRA version: 20.0Level: PTClassification code: 10033128Term: Ovarian cancer Class: 100000004864MedDRA version: 20.0Level: LLTClassification code: 10073060Term: Extragonadal primary germ cell tumor Class: 10029104

CTIS2022-500094-14-00Seagen Inc.254

进行中（未招募）

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of GTX-11 in Healthy SubjectsMedDRA version: 21.1Level: PTClassification code: 10021240Term: Idiopathic pulmonary fibrosis Class: 100000004855MedDRA version: 21.0Level: PTClassification code: 10037383Term: Pulmonary fibrosis Class: 100000004855MedDRA version: 21.1Level: LLTClassification code: 10022619Term: Interstitial pulmonary fibrosis Class: 10038738MedDRA version: 20.0Level: LLTClassification code: 10016660Term: Fibrosis pulmonary Class: 10038738Pulmonary fibrosis

CTIS2023-504426-19-00Gat Therapeutics S.L.60